Last reviewed · How we verify
NCT06960135: Trifecta
Trifecta Achievement in Open and Laparoscopic Partial Nephrectomy
NA trial testing open partial nephrectomy in Trifecta Achievement in 70 participants. Completed in 1 March 2025.
30 May 2024
Quick facts
| Lead sponsor | South Valley University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 June 2022 |
| Primary completion | 30 May 2024 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- open partial nephrectomy
- laparoscopic partial nephrectomy
Conditions studied
- Trifecta Achievement — all drugs for Trifecta Achievement →
- Pentafecta Achievement — all drugs for Pentafecta Achievement →
Sponsor
South Valley University
Who can join
Eligibility, any sex, with Trifecta Achievement or Pentafecta Achievement. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Partial nephrectomy (PN) is a reference standard for the management of the cT1 renal mass, primarily due to better preservation of renal function. The aim of this work was to determine trifecta outcomes of open PN (OPN) and laparoscopic PN (LPN) and identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and ischemia time less than 25 minutes. Objectives: this study pointing to determine trifecta outcomes of OPN and LPN and to identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and Ischemia time less than 25 Minutes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06960135
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other South Valley University trials
Trials by the same sponsor.
- NCT07478718 — Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy · NA · not yet recruiting
- NCT07265154 — Gait Training and Artificial Intelligence · NA · recruiting
- NCT07070544 — Effect of Electromagnetic Field Therapy and Customized Foot Insole on Peripheral Circulation and Ankle-Brachial Pressure · NA · not yet recruiting
- NCT07128472 — Evaluation of IL 12B Genetic Polymorphism (rs3213094) · NA · recruiting
- NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06960135 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by South Valley University
- Last refreshed: 7 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06960135.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing